Last $110.71 USD
Change Today +3.53 / 3.29%
Volume 15.1M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Xetra
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul Berg Ph.D.

Member of Scientific Advisory Board, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 45 board members in 5 different organizations across 4 different industries.

See Board Relationships
87--

Background*

Dr. Paul Berg is a Scientific Advisor at Perlegen Sciences Inc. Dr. Berg serves as a Cahill Professor Emeritus in Cancer Research in the Department of Biochemistry at Stanford University School of Medicine, where he has been on the faculty since 1959. He is the Founder and serves on the Scientific Advisory Board of DNAX Research Institute. He has been a Director of Affymetrix Inc. since 1993. Dr. Berg serves as a Director of Transgene Inc. He serves as a Member of Scientific ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

1993-2011
Former Director and Member of Compensation Committee
1998-2011
Member of Scientific Advisory Board
1998-N/A
Former Director

Education*

PhD
Case Western Reserve University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $110.71 USD +3.53

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.